Bioymifi

Discontinued Product

5372 has been discontinued.

View all Cytokine Receptors products.
Description: DR5 (TRAIL receptor) agonist; induces apoptosis
Chemical Name: 5-[5-[[(5Z)-3-(4-Bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene]methyl]-2-furanyl]-1H-isoindole-1,3(2H)-dione
Purity: ≥97% (HPLC)
Datasheet
Citations
Reviews

Biological Activity for Bioymifi

Bioymifi is a DR5 (TRAIL receptor) agonist. Directly binds extracellular domain of DR5 (Kd = 1.2 μM) and induces the formation of DR5 aggregates. Induces apoptosis of glioblastoma cells.

Technical Data for Bioymifi

M. Wt 494.32
Formula C22H12BrN3O4S
Storage Store at +4°C
Purity ≥97% (HPLC)
CAS Number 1420071-30-2
PubChem ID 70678419
InChI Key ULBOWKXOFOTCMU-NLDKGBHCSA-N
Smiles BrC1=CC=C(N3C(/C(SC3=N)=C/C2=CC=C(C4=CC=C(C(NC5=O)=O)C5=C4)O2)=O)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for Bioymifi

References are publications that support the biological activity of the product.

Wang et al (2013) Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat.Chem.Biol. 9 84 PMID: 23292651

View Related Products by Product Action

View all Cytokine Receptor Agonists

Keywords: Bioymifi, Bioymifi supplier, TRAIL, tumor, necrosis, factor-related, apoptosis-inducing, ligand, DR5, TNF, agonists, agonism, Cytokine, Receptors, Apoptosis, Inducers, 5372, Tocris Bioscience

Citations for Bioymifi

Citations are publications that use Tocris products.

Currently there are no citations for Bioymifi.

Reviews for Bioymifi

There are currently no reviews for this product. Be the first to review Bioymifi and earn rewards!

Have you used Bioymifi?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review